中文

Illumina (ILMN)

Life-science tools and diagnostics

Close on Nov 11, 2026 (from our latest Long View update): $212.93

Market value
$32.2Bat the Nov 11 close
Revenue growth
+6%12 months to Sep 27, 2026 (10-Q)
FCF margin
23%12 months to Sep 27, 2026 (10-Q)
Net debt
$454Mat Sep 27, 2026
Worst fall since listing
−96.1%Sep 1, 2000 to Mar 13, 2003; back to that high in Jul 2007

About the company

Latest

  • Down 18.6% Move
    Illumina falls 19% even as it raises its full-year forecast

The Long View

Illumina’s 2021 purchase of GRAIL, closed while European regulators were still reviewing it, led to a prohibition, a fine, about $6.6B of write-downs and a change of chief executive before GRAIL was spun off in 2024.

Self-funding

▲ better · ▼ worse · ⚠ watch, latest quarter · share count · cash

Updated Nov 12, 2026

Read the Long View →

Our View Opinion

Our analysis of the company and our scenarios for 2030: median value, range, chance of beating the hurdle and the biggest risk.

No Our View yet. Request one →

More of our coverage that names Illumina

Long-term fundamentals

Annual results for Illumina, FY2009–FY2025, as reported in its 10-K filings.

Revenue and free cash flow

Revenue went from $666M in FY2009 to $4.3B in FY2025. Free cash flow was positive in 17 of the 17 years shown; FY2025: $931M. Each year's figures are in the table below. $0$2B$4B$6B ’09 ’11 ’13 ’15 ’17 ’19 ’21 ’23 ’25

Revenue went from $666M in FY2009 to $4.3B in FY2025.

Free cash flow was positive in 17 of the 17 years shown; FY2025: $931M.

Margins

Operating margin was 19% in FY2025, vs 18% in FY2020. Gross margin was 66% in FY2025, vs 68% in FY2020. Each year's figures are in the table below. −100%−50%0%50%100% ’09’11’13’15’17’19’21’23’25

Operating margin was 19% in FY2025, vs 18% in FY2020.

Gross margin was 66% in FY2025, vs 68% in FY2020.

Diluted share count

The diluted share count rose 5% from FY2020 to FY2025, to 156M. Each year's figures are in the table below. 130M140M150M160M ’09’11’13’15’17’19’21’23’25

The diluted share count rose 5% from FY2020 to FY2025, to 156M.

Results and cash flow

Fiscal yearRevenueGross marginOperating marginNet incomeOperating cash flowCapital spendingFree cash flow
FY2025$4.3B66%19%$850M$1.1B$148M$931M
FY2024$4.4B65%−19%−$1.2B$837M$128M$709M
FY2023$4.5B61%−24%−$1.2B$478M$195M$283M
FY2022$4.6B65%−91%−$4.4B$392M$286M$106M
FY2021$4.5B70%−3%$762M$545M$208M$337M
FY2020$3.2B68%18%$656M$1.1B$189M$891M
FY2019$3.5B70%28%$1.0B$1.1B$209M$842M
FY2018$3.3B69%26%$826M$1.1B$296M$846M
FY2017$2.8B66%22%$726M$875M$310M$565M
FY2016$2.4B69%24%$463M$779M$260M$519M
FY2015$2.2B70%28%$462M$786M$143M$643M
FY2014$1.9B70%28%$353M$501M$106M$395M
FY2013$1.4B64%9%$125M$386M$79M$307M
FY2012$1.1B67%17%$151M$292M$69M$223M
FY2011$1.1B67%19%$87M$358M$78M$280M
FY2010$903M67%23%$125M$273M$50M$223M
FY2009$666M68%19%$72M$172M$53M$120M

Shares, cash, debt and payouts

Fiscal yearDiluted sharesCash and investmentsDebtStock-based payDividends paidBuybacks
FY2025156M$1.4B$2.0B$275M—$742M
FY2024159M$1.1B$2.0B$370M—$116M
FY2023158M$1.0B$1.5B$380M—$0
FY2022157M$2.0B$2.7B$366M—$0
FY2021151M$1.2B$1.7B$754M—$0
FY2020148M$3.1B$1.2B$194M—$736M
FY2019149M$3.3B$1.1B$194M—$324M
FY2018149M$3.5B$2.0B$193M—$201M
FY2017148M$2.1B$1.2B$164M—$251M
FY2016148M$1.6B$1.1B$129M—$249M
FY2015149M$1.4B$1.1B$133M—$274M
FY2014149M$1.3B$1.3B$153M—$237M
FY2013140M$1.2B$869M$106M—$50M
FY2012134M$1.4B$805M$94M—$83M
FY2011139M$1.2B$807M$92M—$570M
FY2010143M$894M—$72M—$44M
FY2009137M$694M—$61M—$175M

Source: company 10-K filings via SEC EDGAR (XBRL data); fiscal years. Data fetched Nov 12, 2026. Free cash flow is operating cash flow minus capital spending (our calculation; the company's own definition may differ). Margins are a share of revenue. "—" means the figure is not in the 10-K data.

  • Cash for FY2019-2025 includes restricted cash (the only cash total tagged).

Returns by year

YearILMNS&P 500
2019+10.6%+31.5%
2020+11.5%+18.4%
2021+2.8%+28.7%
2022−46.9%−18.1%
2023−31.1%+26.3%
2024−1.3%+25.0%
2025−1.8%+17.9%
2026 to date+53.0%+5.9%

Total return, with dividends reinvested: each year from the last close of the year before to the last close of the year; 2026 to date runs to the Nov 19, 2026 close. The S&P 500 is its total return index. Our calculation from Yahoo Finance daily closes and adjusted closes; not investment advice.

Other companies we cover in Healthcare

Show all 26

Questions about Illumina

Why did Illumina stock fall on Oct 30, 2026?
Illumina shares fell about 19% on Friday, after the drop began after hours on Thursday, despite an earnings beat and higher full-year forecasts. StockStory called revenue a miss, but Illumina's $37 million reduction for expected customer tariff credits complicates that comparison. The reporting so far does not establish what drove the selling. Read the article →